Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome: a Randomized Controlled Trial

NCT06602167 is registered in ClinicalTrials.gov with Affiliated Hospital of Qinghai University as lead sponsor.

NCT NCT06602167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06602167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome: a Randomized Controlled Trial
Lead sponsor
Affiliated Hospital of Qinghai University
Phase
Not applicable
Overall status
Recruiting
Start date
October 8, 2024
Completion date
December 31, 2027
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, capecitabine, electroacupuncture, gastrointestinal cancers, hand-foot syndrome, self-administered acupressure